Cytological monitoring of peripheral blood, bronchoalveolar lavage fluid, and transbronchial biopsy specimens during acute rejection and cytomegalovirus infection in lung and heart-lung allograft recipients

Clinical Transplantation

Volumn 15, Issue 2, 2001, Pages 77-88

  Tikkanen, Jussi ^a   Lemström, Karl ^a   Halme, Maija ^b   Pakkala, Seppo ^a   Taskinen, Eero ^a   Koskinen, Petri ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

CMV antigenemia; Cytological monitoring; Lung; Rejection; Transplantation

Indexed keywords

ACICLOVIR; AZATHIOPRINE; CYCLOSPORIN A; GANCICLOVIR; METHYLPREDNISOLONE; MONOCLONAL ANTIBODY; OKT 3; STEROID; THYMOCYTE ANTIBODY; VALACICLOVIR;

ADULT; ALLOGRAFT; ANALYSIS; ARTICLE; BASOPHIL; BASOPHILIA; BLOOD; CELL COMPOSITION; CHEMOPROPHYLAXIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOLOGY; CYTOMEGALOVIRUS INFECTION; DIAGNOSTIC PROCEDURE; EOSINOPHIL; FEMALE; GRAFT REJECTION; HEART LUNG TRANSPLANTATION; HUMAN; HUMAN TISSUE; LUNG LAVAGE; LYMPHOCYTE COUNT; LYMPHOCYTIC INFILTRATION; MALE; MONITORING; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECIPIENT; SAMPLE; SENSITIVITY AND SPECIFICITY; STANDARD; TIME; TRANSBRONCHIAL BIOPSY;

ACUTE DISEASE; ADULT; ANTIGENS, VIRAL; ANTIVIRAL AGENTS; BASOPHILS; BIOPSY; BRONCHOALVEOLAR LAVAGE FLUID; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; EOSINOPHILS; FEMALE; GANCICLOVIR; GRAFT REJECTION; HEART-LUNG TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LEUKOCYTE COUNT; LUNG; LUNG TRANSPLANTATION; LYMPHOCYTE SUBSETS; LYMPHOCYTES; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY;

EID: 0035093294     PISSN: 09020063     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-0012.2001.150201.x     Document Type: Article

References (40)

1. Treatment of end-stage chronic obstructive pulmonary disease with double lung transplantation
2. Results of single-lung transplantation for bilateral pulmonary fibrosis
3. Lung transplantation
4. The registry of the International Society for Heart and Lung Transplantation: Fourteenth official report - 1997
5. Bronchiolitis obliterans syndrome in heart-lung transplantation
6. Cytomegalovirus serologic status and postoperative infection correlated with risk of developing chronic rejection after pulmonary transplantation
7. Revision of the 1990 working formulation for the classification of pulmonary allograft rejection: Lung rejection study group
8. Direct detection of cytomegalovirus in periphearl blood leukocytes - A review of the antigenemia assay and polymerase chain
9. Monitoring antigenemia is useful in guiding treatment of severe cytomegalovirus disease after organ transplantation
10. Cytomegalovirus infections in heart and heart lung transplant recipients
11. Analysis of time-dependent risks for infection, rejection, and death after pulmonary transplantation
12. Ganciclovir treatment of life- or sight-threatening cytomegalovirus infection: Experience in 314 immunocompromised patients
13. A comparison of ganciclovir and acyclovir to prevent cytomegalovirus after lung transplantation
14. Ganciclovir treatment of cytomegalovirus disease in transplant recipients and other immunocompromised hosts
15. Antigen test for early diagnosis of active treatment of cytomegalovirus infection in heart transplant recipients
16. Analysis of T lymphocyte subsets in cytomegalovirus mononucleosis
17. Early cellular events in the lung allograft
18. The correlation between symptomatic CMV infection and CMV antigenemia in heart allograft recipients
19. Transbronchial lung biopsy for the diagnosis of rejection in heart-lung transplantation patients
20. Immunological monitoring of lung transplant patients by bronchoalveolar lavage analysis
21. Altered nonspecific lymphocyte cytotoxicity in bronchoalveolar lavage of lung transplant recipients
22. Cell profiles in serial bronchoalveolar lavage after human heart-lung transplantation
23. Sensitivity and specificity of cyto-immunological monitoring in correlation with endomyocardial biopsies in heart transplant patients
24. Immunologic monitoring of heart transplant patients under cyclosporine immunosuppression
25. Cytoimmunologic monitoring (CIM) for differentiation between cardiac rejection and viral, bacterial, or fungal infection: Its specificity and sensitivity
26. Proliferative responses of bronchoalveolar lavage lymphocytes from heart/lung transplant patients
27. Differentiation of class I and class II directed donor-specific alloreactivity in bronchoalveolar lavage lymphocytes from lung transplant recipients
28. Basophils and mast cells in renal allograft rejection
29. The potential role of mast cells in lung allograft rejection
30. New concepts about the mast cell
31. Morphometric inflammatory cell analysis of human liver allograft biopsies
32. The importance of eosinophil cells in kidney allograft rejection
33. Bronchoalveolar lavage neutrophilia is associated with obliterative bronchiolitis after lung transplantation: Role of IL-8
34. Graft eosinophilia in lung transplantation
35. Characterization of a factor produced by human T cell clones exhibiting eosinophil activating and burst promoting activities
36. Diagnosis of rejection in rat lung allografts by bronchoalveolar lavage
37. Cytomegalovirus infection-associated generalized immune activation in heart allograft recipients: A study of cellular events in peripheral blood and endomyocardial biopsy specimens
38. Bronchoalveolar lavage in lung transplantation
39. HLA-restricted cytotoxic lymphocytes are an early immune response and important defence mechanism in cytomegalovirus infections